MD Anderson and Federation Bio collaborate to design and manufacture a synthetic microbial consortium

3D render of a medical background with DNA strands

The University of Texas MD Anderson Cancer Center and Federation Bio today announced a strategic collaboration to design and manufacture a complex, synthetic microbial consortium with the goal of expanding the number of cancer patients who respond to immunotherapy.

Back-to-school blues are normal, so how can you tell if it’s something more serious?

Previous article

New study suggests Omicron BA.1 breakthrough infection drives long-term remodeling of memory B cell repertoire in vaccinated populations

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News